Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Memira
Mandate

Vinge advises on the sale of Memira

July 08, 2019 M&A

Vinge has advised Patricia Industries AB, part of Investor AB, and other shareholders in Memira Holding AB in connection with the sale of the company to the Dutch company Bergman Clinics BV.

With 47 clinics, Memira is the Nordic Region’s leading chain providing sight correction operations and one of the leading actors in the world in relation to change of lenses.

The transaction is subject to customary closing conditions.

Vinge’s team primarily consisted of Johan Winnerblad, Kristina Ekberg, Karl Klackenberg, Martin Cronsioe, Milad Kamali, Daniel Wendelsson, Maria Schultzberg, Henrik Wastensson and Sofie Sundin. 

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

 Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

 Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026